PERITONEAL CANCER
Clinical trials for PERITONEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new PERITONEAL CANCER trials appear
Sign up with your email to follow new studies for PERITONEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted 'Smart Bomb' drug tested for Tough-to-Treat gynecologic cancers
Disease control CompletedThis study tested an experimental drug called mirvetuximab soravtansine for women with recurrent ovarian, peritoneal, or fallopian tube cancers that had previously responded well to platinum-based chemotherapy. The drug is designed like a 'smart bomb' to target and kill cancer ce…
Matched conditions: PERITONEAL CANCER
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New scan method could personalize treatment for Tough-to-Treat abdominal cancers
Diagnosis CompletedThis study tested whether a special type of scan (FDG-PET/CT) could be used to help select patients and monitor their response to a targeted chemotherapy treatment for advanced abdominal cancer that has spread to the abdominal lining. The pilot study involved 16 patients receivin…
Matched conditions: PERITONEAL CANCER
Sponsor: Odense University Hospital • Aim: Diagnosis
Last updated Apr 01, 2026 23:11 UTC
-
Smart tech aims to guide cancer survivors through genetic testing maze
Knowledge-focused CompletedThis study tested a digital tool designed to help cancer survivors learn about and decide whether to get genetic testing for hereditary cancer risk. Researchers wanted to see if this smart technology was easy to use and if it encouraged more people to get tested. They compared th…
Matched conditions: PERITONEAL CANCER
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
Scientists track 1500 patients to decode ovarian Cancer's genetic secrets
Knowledge-focused CompletedThis study aims to understand how specific genetic changes in ovarian, fallopian tube, or peritoneal cancer affect how the disease progresses and responds to treatment. Researchers will collect medical information and tumor samples from 1500 French patients with advanced-stage ca…
Matched conditions: PERITONEAL CANCER
Sponsor: ARCAGY/ GINECO GROUP • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC